AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Medicalgorithmics S.A.

AGM Information Jun 13, 2025

5705_rns_2025-06-13_23b843f8-9f08-44b2-b20e-b781226380bf.html

AGM Information

Open in Viewer

Opens in native device viewer

Report Content Submissionby a shareholder of candidates for the Supervisory Board together withthe content of draft resolutions submitted as part of the agenda of theOrdinary General Meeting of Medicalgorithmics S.A. convened for June 17,2025

CurrentReport No: 11/2025

Date:June 13th, 2025

LegalBasis: Article 56(1)(2) of the Act on Public Offering - Current andPeriodic Information

TheManagement Board of Medicalgorithmics S.A. with its registered office inWarsaw (the "Company") hereby informs that on June 13, 2025,the Company received from the shareholder - Biofund Capital ManagementLLC ("BioFund") a submission of draft resolutions concerningthe matter included in the agenda of the Ordinary General Meeting of theCompany, which was convened for June 17, 2025, at 2:00 p.m., i.e. thenotification:

1)toitem 14 of the agenda, which provides for the adoption of resolutions onthe appointment of members of the Supervisory Board for the next term ofoffice, together with the nomination of Mr. Krzysztof Siemionow forMember of the Supervisory Board of the Company and Mr. Paweł Lewicki forMember of the Supervisory Board of the Company in the election ofmembers of the Supervisory Board at the Ordinary General Meeting of theCompany convened for June 17, 2025.

Inaccordance with the justification for the shareholder's request, theagenda of the Ordinary General Meeting included an item concerning theadoption of resolutions on the appointment of members of the SupervisoryBoard for the next term of office. The proposed draft resolutions are inline with the agenda introduced by the Management Board. The advancesubmission by BioFund of the candidacy of Mr. Krzysztof Siemionow for aMember of the Supervisory Board of the Company and Mr. Paweł Lewicki fora Member of the Supervisory Board of the Company is also in line withgood market practices.

Theshareholder's request was accompanied by draft resolutions, resumes(BIO) of candidates, and the consent of Mr. Kris (Krzysztof) Siemionowand Mr. Paul (Paweł) Lewicki to run for and be appointed to theCompany's Supervisory Board.

Thedraft resolutions submitted by the shareholder on the items on theagenda and the resumes (BIO) of the candidates are attached to thereport. Thedraft resolutions submitted by the shareholder on the matter included inthe agenda and the resumes (BIO) of the candidates are attached to thereport.

DetailedLegal Basis:§ 19(1)(4) of the Regulation of the Minister of Finance of March 29,2018, on current and periodic information provided by issuers ofsecurities and the conditions for recognizing information required bythe laws of a non-member state as equivalent.

Talk to a Data Expert

Have a question? We'll get back to you promptly.